Just another DEAD PT WALKING?

Last night I was contacted by a chronic pain pt. This pt is a chronic pain pt, but what she described to me was that she had a shattered patella. In seeing her PCP, her BP was 220/110 and her PCP told the pt that he could not prescribe any more pain meds. He was […]

When is AG Bondi going to enforce 42 USC 1395 and quit discriminating against disabled Seniors

It is FED AG Pam Bondi who is in charge of seeing that all of our laws are enforced.  RFK Jr wants to make America Healthy Again. Yet Bondi seems to be out of step with MAHA. Can anyone be HEALTHY and have their QOL that is in the gutter and/or circling the drain? This […]

AI answers are not infallible and incorrect information can be challenged to make them look again

Here are two inquiries and responses from Grok, which can be found within the X/Twitter website. The first was fairly factual. IMO, most of the opioid deaths were from Pharma opioids that were diverted. People would go to a “Oxy doc” and get some meds and sell half of what they got, to help pay […]

The United States Files False Claims Act Complaint Against Three National Health Insurance Companies and Three Brokers Alleging Unlawful Kickbacks and Discrimination Against Disabled Americans

The United States Files False Claims Act Complaint Against Three National Health Insurance Companies and Three Brokers Alleging Unlawful Kickbacks and Discrimination Against Disabled Americans https://www.justice.gov/opa/pr/united-states-files-false-claims-act-complaint-against-three-national-health-insurance The United States filed a complaint today under the False Claims Act (FCA) against three of the nation’s largest health insurance companies — Aetna Inc. and affiliates, Elevance Health Inc. […]

How the FDA Helped Ignite, and Then Worsened, the Opioid Crisis

I have never seen anyone giving Congress any part of their contribution to the theoretical opioid crisis, but this may be their contribution that was signed into law by Pres Clinton. S. 3163 (106th): A bill to designate the calendar decade beginning on January 1, 2001, as the “Decade of Pain Control and Research” This […]

When an Algorithm Guides Pain Management: The Growing Backlash Against NarxCare Scores

When an Algorithm Guides Pain Management: The Growing Backlash Against NarxCare Scores https://www.medscape.com/viewarticle/when-algorithm-guides-pain-management-growing-backlash-2025a100091n This article is the first in a series on prescription drug monitoring programs and analysis tools designed to give clinician a view of how likely their patient is to abuse or overdose on a prescribed controlled substance. The second part dives into […]

FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering

FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering

NO ONE IS ABOVE THE LAW -EXCEPT THOSE WHO ARE IN CHARGE OF ENFORCING OUR LAWS

Read this and weep – AGs and National Opioid Agreement – nicely put CPs OUT IN THE COLD  It would appear that many different parts of our federal and state bureaucracy are focusing on cutting the availability of FDA-approved controlled opioids. I guess that the DOJ/DEA was not shutting down practitioners’ offices fast enough.  More […]

New Blood Pressure Guidelines Lower Treatment Target

Apparently, the author of this article did not wish to call out what is still a hypertensive crisis level. Which it is a BP of > 180/120. I can’t count the number of times that a pt has told me that after their pain meds have been reduced and their blood pressure would go up […]

The Coming Pharma Tariffs: Decoding Trump’s High-Stakes Bet on Drug Supply Chains

The Coming Pharma Tariffs: Decoding Trump’s High-Stakes Bet on Drug Supply Chains https://www.daily-remedy.com/the-coming-pharma-tariffs-decoding-trumps-high-stakes-bet-on-drug-supply-chains/ As former President Trump signals sweeping tariffs on foreign pharmaceuticals, policymakers, investors, and patients must brace for consequences that go far beyond price tags Introduction: The Tariff Test Case No One Is Talking About For all the attention given to tariffs on […]